Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2007
10/25/2007WO2007080621A8 Luminescent transgenic non human animals, progeny, cell derivatives and uses thereof
10/25/2007WO2007077423A3 Growth hormone variations
10/25/2007WO2007052165A3 A lentiviral vector-based vaccine
10/25/2007WO2007018482A3 Polypeptides for inducing a protective immune response against staphylococcus aureus
10/25/2007WO2006105998A3 Treatment of cognitive and learning impairment
10/25/2007WO2006102438A3 Methods and compositions for irrigation of mucosal tissues
10/25/2007WO2006099308A3 A method of weak partitioning chromatography
10/25/2007WO2006076410A3 Li-key/antigenic epitope hybrid peptide vaccines
10/25/2007WO2005078101A3 Use of genes encoding outward potassium channels for modifying at least one phenotype linked to the size and organic acid content of at least one plant storage organ
10/25/2007WO2005034877A3 G-csf transferrin fusion proteins
10/25/2007WO2005013916A3 Targeting cellular entry, cell survival, and pathogenicity by dynein light chain 1/pin in human cells
10/25/2007WO2004075725A3 Bcrm-1 genes and uses thereof
10/25/2007WO2002099074A3 Slc7s as modifiers of the p53 pathway and methods of use
10/25/2007WO2002004651A3 Jointless gene of tomato
10/25/2007WO2001040300A8 Protease resistant tumor suppressor p14(arf)
10/25/2007US20070250964 Ice Recrystallisation Inhibition Protein or Antifreeze Proteins from Deschampsia, Lolium and Festuca Species of Grass
10/25/2007US20070250962 Nucleotide Sequences and Polypeptides Encoded Thereby Useful for Increasing Plant Size and Increasing the Number and Size of Leaves
10/25/2007US20070250960 Generation of Plants with Altered Oil Content
10/25/2007US20070250945 Usage of Mad-Box Genes in Fruit & Seed Development by Regulating Active Gibberellin Synthesis
10/25/2007US20070250941 VEGF Receptor Conditional Knockout Animals and Methods of Use
10/25/2007US20070249815 purifying bone-derived osteogenic proteins including demineralization, protein extraction, high molecular weight ultrafiltration, low molecular weight ultrafiltration, and recovery processes; obtaining osteogenic proteins from mammalian bone tissue
10/25/2007US20070249814 Transcriptional regulatory factor
10/25/2007US20070249810 DdrA protein; used to decrease exonuclease damage in DNA in relation to natural exonuclease damage that would occur in its absence
10/25/2007US20070249808 Multiple Sclerosis-related superantigen
10/25/2007US20070249807 Polypeptide for preventing or reducing ischemia, systemic inflammatory response
10/25/2007US20070249805 Clay-binding peptides and methods of use
10/25/2007US20070249734 Method, Composition and Kit for Detecting Phosphatidylserine (Ps) on Cell Membranes
10/25/2007US20070249553 Vaccine And Nucleic Acids Capable Of Protecting Poultry Against Colonisation By Campylobacter
10/25/2007US20070249538 tumor necrosis factor (TNF) antagonists and corresponding nucleic acids; inflammatory diseases; the proteins lack exon 7 and which can bind TNF and can act as a TNF antagonist
10/25/2007US20070249533 Il-17a and il-17f antagonists and methods of using the same
10/25/2007US20070249532 Modified growth hormones
10/25/2007US20070249531 Method for the Detection of Autoantibodies Against Specific Peptides and Its Use in Diagnosis and Treatment of Pregnancy-Loss or Infertility
10/25/2007US20070249530 Bcma Polypeptides and Uses Thereof
10/25/2007US20070249529 Compositions Comprising Polypeptides
10/25/2007US20070249521 polypeptide having antimicrobial activity, having an amino acid sequence selected from e.g. Arg Arg Arg Pro Pro Arg Leu Pro Arg Pro Phe Pro; Phe Arg Pro Pro Pro Arg Pro Arg Pro Leu Pro Val; detergents, animal feed
10/25/2007US20070249061 Screening method of new drug candidates using protein interaction happening after binding a small amount of protein on high sensitive protein chip; can be used for research of protein-protein interactions; peptide composition for treating cancer
10/25/2007US20070249060 Determination of Proteins and/or Other Molecules Using Mass Spectroscopy
10/25/2007US20070249056 Peptide and Protein Fragmentation by Lysine Residue Originated Reactions
10/25/2007US20070249022 Osteoporosis; transforming growth factors; pyrogen-free
10/25/2007US20070249021 Deglycosylated and Desialidated Long Pentraxin Ptx3
10/25/2007US20070249020 Cytokine zcytor17 ligand polypeptides and polynucleotides
10/25/2007US20070249017 Polynucleotides Encoding Polypeptides Involved in Amino Acid Biosynthesis in Methylophilus Methylotrophus
10/25/2007US20070249015 Method of isolation and purification of trypsin from pronase protease and use thereof
10/25/2007US20070249014 Labeling and detection of post translationally modified proteins
10/25/2007US20070248996 Modulators of beta-amyloid peptide aggregation comprising D-amino acids
10/25/2007US20070248995 Molecules
10/25/2007US20070248988 Binding molecules and methods of use thereof
10/25/2007US20070248972 Page-4, an X-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor
10/25/2007US20070248679 Vaccine
10/25/2007US20070248627 Gene Therapy for Tumors Using Minus-Strand Rna Viral Vectors Encoding Immunostimulatory Cytokines
10/25/2007US20070248626 Recombinant toxin fragments
10/25/2007US20070248617 Medical Uses of Carrier Conjugates of Non-Human Tnf -Peptides
10/25/2007US20070248616 Canine Respiratory Coronavirus (Crcv) Spike Protein, Polymerase and Hemagglutinin/Esterase
10/25/2007US20070248615 T helper cell epitopes
10/25/2007US20070248606 Treatment of Alzheimer's disease
10/25/2007US20070248605 Fibroblast Growth Factor Receptors 1,2,3, and 4 as Targets for Therapeutic Intervention
10/25/2007US20070248598 Recombinant anti-VLA4 antibody molecules
10/25/2007US20070248593 Identifying and characterizing novel human secreted proteins and their genes ; promotes vascularization; screening methods
10/25/2007US20070248589 Spatial for Altering Cell Proliferation
10/25/2007US20070248588 Novel Compositions and Methods for the Treatment of Immune-Related Diseases
10/25/2007US20070248584 Immunomodulating Compositions, Uses Therefore and Processes for Their Production
10/25/2007US20070248579 Use of Secreted Protein Products for Preventing and Treating Pancreatic Diseases and/or Obesity and/or Metabolic Syndrome
10/25/2007US20070248573 Chimeric Bacteriophages, Chimeric Phage-Like Particles, and Chimeric Phage Ghost Particles, Methods for Their Production and Use
10/25/2007US20070248545 Use of the receptor GPR86
10/25/2007US20070248543 Chicken Deoxycytidine and Deoxyadenosine Kinase Enzymes and Their Use
10/25/2007US20070248539 AgRM2 antigen
10/25/2007US20070248536 conjugate between a polypeptide based on ubiquitin and a functional component wherein the respective polypeptide molecule has a binding property for the specific binding to a ligand which is altered as compared to the wild type polypeptide; diagnostic kit
10/25/2007DE102006018583A1 Abwehrstoff gegen die Bildung von Haustorien als Pflanzenschutzmittel gegen Pflanzenparasiten Antitoxin against the formation of haustoria as plant protection agents against plant parasitic
10/25/2007DE10100305B4 Knorpelzellmarker, Verfahren sowie Verwendungen desselben The same chondrocyte marker, processes and uses
10/25/2007CA2650061A1 Method for modifying the atp/adp ratio in cells
10/25/2007CA2649847A1 Novel enterococcus and streptococcus strains and bacteriocins
10/25/2007CA2649431A1 N protein fusion proteins of a virus in the paramyxoviridae-protein of interest family and their use for intracellular vectorization and vaccination
10/25/2007CA2649303A1 Homogeneous erythropoietin and other peptides and proteins, methods and intermediates for their preparation
10/25/2007CA2649296A1 Methods for designing and synthesizing directed sequence polymer compositions via the directed expansion of epitope permeability
10/25/2007CA2649269A1 Protein complex and process for producing the same
10/25/2007CA2649250A1 Dopaminergic neuron progenitor cell marker 187a5
10/25/2007CA2649148A1 Taurine transporter gene
10/25/2007CA2648925A1 Tetramerizing polypeptides and methods of use
10/25/2007CA2648849A1 Binding proteins comprising immunoglobulin hinge and fc regions having altered fc effector functions
10/25/2007CA2648322A1 Disheveled pdz modulators
10/25/2007CA2647944A1 Active potassium channel transporters (akt) and their use to create stress tolerant plants
10/25/2007CA2646253A1 Method for cloning and expression of nrui restriction endonuclease
10/25/2007CA2645766A1 Immunogenic wt-1 peptides and methods of use thereof
10/25/2007CA2636424A1 Immunostimulatory combinations of tnfrsf, tlr, nlr, rhr, purinergic receptor, and cytokine receptor agonists for vaccines and tumor immunotherapy
10/24/2007EP1847620A2 Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer
10/24/2007EP1847613A2 Suppression of specific classes of soybean seed protein genes
10/24/2007EP1847609A1 BASB205 polypeptides and polynucleotides coding therefor
10/24/2007EP1847608A1 Member of the TNF ligand family
10/24/2007EP1847607A1 Human p51 protein and antibody
10/24/2007EP1847606A2 Mitogenic regulators
10/24/2007EP1847600A1 Specific protease for inactivation of human tumour necrosis factor-alpha
10/24/2007EP1847550A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
10/24/2007EP1847549A2 Papillomavirus polyprotein constructs
10/24/2007EP1847273A1 April receptor (BCMA) and uses thereof
10/24/2007EP1846769A1 Porcine intrinsic factor
10/24/2007EP1846561A1 Nucleotide sequences encoding ramosa3 and sister of ramosa3 and methods of use for same
10/24/2007EP1846549A1 Porcine mast cell lines that produce heparin-type molecules
10/24/2007EP1846453A2 Inhibition of islet amyloid polypeptide (iapp) aggregation for the treatment of type 2 diabetes
10/24/2007EP1846452A1 Monoclonal antibodies against angiopoietin-like protein 4 (angptl4 )
10/24/2007EP1846451A1 Specific binding members for ngf